Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update
May 10, 2016 06:33 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., May 10, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the first quarter...
Bellerophon Reports 2015 Financial Results and Provides Business Update
March 21, 2016 06:03 ET
|
Bellerophon Therapeutics LLC
– Company Receives Final FDA Confirmation to Initiate Phase 3 Studies Using Next Generation INOpulse Device – – Management to Host a Conference Call Today at 8:30 a.m. ET – WARREN, N.J.,...
Bellerophon Therapeutics to Hold Full Year 2015 Financial Results Conference Call on Monday March 21, 2016
March 14, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., March 14, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will release its full year 2015...
Bellerophon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
March 04, 2016 17:32 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., March 04, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will present in the Cowen and...
Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 02, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., March 02, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported that in connection with the appointment of...
Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer
February 23, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Fabian Tenenbaum as Chief...
Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member
February 16, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Mary Ann Cloyd as an...
Bellerophon Therapeutics Announces Positive Data From the Final Analysis of the Phase 2 Long-Term Extension Study of INOpulse for Treatment of Pulmonary Arterial Hypertension
February 09, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive data from the final analysis of...
Bellerophon to Participate in LEERINK Partners 5th Annual Global Healthcare Conference
February 03, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will participate in LEERINK...
Bellerophon Therapeutics Announces Notice of Intention to Grant a European Patent Supporting Its INOpulse Program
January 21, 2016 08:03 ET
|
Bellerophon Therapeutics LLC
WARREN, N.J., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that the European Patent Office has...